Alnylam Pharmaceuticals, Inc. (ALNY) - NASDAQ
  • Alexander Valtsev | Send Message 6 Jul

    Better Buy: Ionis Pharmaceuticals vs. Alnylam Pharmaceuticals: http://bit.ly/050716IONS $IONS $ALNY
    Reply
      • Alexander Valtsev | Send Message 6 Jul

        Why Alnylam Pharmaceuticals, Inc. Is Down 37.3% This Year: http://bit.ly/050716ALNY $ALNY
        Reply
          • EP Vantage | Send Message 23 Jun

            Amyloidosis Pipeline Still Looks To Alnylam For Answers $ALNY http://seekingalpha.com/a/2de20
            Reply
              • William Meyers | Send Message 22 Jun

                Alnylam Readouts Could Propel In 2017-2018 $ALNY http://seekingalpha.com/a/2ddqq
                Reply
                  • Andrea Malizia | Send Message 27 May

                    Alnylam Pharmaceuticals, Competitive Strategy Report $ALNY, $IONS, $GSK http://seekingalpha.com/p/2wq0f
                    Reply
                      • Bret Jensen | Send Message 27 May

                        Biotech Forum Daily Digest: Some Good News For Relypsa! Spotlight On Alnylam Pharmaceuticals. Major... $ALNY http://seekingalpha.com/a/2d9m4
                        Reply
                          • Rod Raynovich | Send Message 27 May

                            Biotech Rally Fades But Plenty Of Big Movers: ASCO June 6 $IBB, $ALNY http://seekingalpha.com/p/2wq07
                            Reply
                              • Michael Clark | Send Message 26 May

                                GOLD STOCKS UNCERTAIN; BIOTECH RECOVERING? $ALNY http://seekingalpha.com/p/2wpw6
                                Reply
                                  • beleggersclub | Send Message 22 May

                                    (Typical rally) $GGB , $ALNY and $BC http://tinyurl.com/zjr2obu
                                    Reply
                                      • StockConsultant | Send Message 18 Apr

                                        $ALNY $ANAC $ANF $PETX $VRA stocks at support w/ high trade quality http://bit.ly/1pnIarC #stocks
                                        Reply
                                          Company Description
                                          Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases.... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States